RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)

NCT03044665 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

3780

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Cerebrovascular Disease
Peripheral Atherosclerotic Disease

Interventions

DRUG: Rosuvastatin
DRUG: Rosuvastatin plus ezetimibe

Sponsor

Yonsei University